Expanded Access to Provide Larotrectinib for the Treatment of Cancers With a NTRK Gene Fusion
Clinical trial NCT03025360 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03025360
- Sponsor
- Bayer
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.